19-1221273-G-C
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_000455.5(STK11):c.795G>C(p.Glu265Asp) variant causes a missense change. The variant allele was found at a frequency of 0.000000685 in 1,459,716 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E265A) has been classified as Uncertain significance.
Frequency
Consequence
NM_000455.5 missense
Scores
Clinical Significance
Conservation
Publications
- familial pancreatic carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Peutz-Jeghers syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Genomics England PanelApp, G2P
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| STK11 | NM_000455.5 | c.795G>C | p.Glu265Asp | missense_variant | Exon 6 of 10 | ENST00000326873.12 | NP_000446.1 | |
| STK11 | NM_001407255.1 | c.795G>C | p.Glu265Asp | missense_variant | Exon 6 of 9 | NP_001394184.1 | ||
| STK11 | NR_176325.1 | n.2062G>C | non_coding_transcript_exon_variant | Exon 7 of 11 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| STK11 | ENST00000326873.12 | c.795G>C | p.Glu265Asp | missense_variant | Exon 6 of 10 | 1 | NM_000455.5 | ENSP00000324856.6 | ||
| STK11 | ENST00000652231.1 | c.795G>C | p.Glu265Asp | missense_variant | Exon 6 of 9 | ENSP00000498804.1 | ||||
| STK11 | ENST00000585748.3 | c.423G>C | p.Glu141Asp | missense_variant | Exon 8 of 12 | 3 | ENSP00000477641.2 | |||
| STK11 | ENST00000593219.6 | n.*620G>C | non_coding_transcript_exon_variant | Exon 7 of 11 | 3 | ENSP00000466610.1 | ||||
| STK11 | ENST00000593219.6 | n.*620G>C | 3_prime_UTR_variant | Exon 7 of 11 | 3 | ENSP00000466610.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000406 AC: 1AN: 246466 AF XY: 0.00000745 show subpopulations
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1459716Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726052 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Peutz-Jeghers syndrome Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt STK11 protein function. This variant has not been reported in the literature in individuals with STK11-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces glutamic acid with aspartic acid at codon 265 of the STK11 protein (p.Glu265Asp). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and aspartic acid. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at